Vaporox

Founded in 2016 and headquartered in Centennial, Colorado, Vaporox was formed to commercialize Vaporous Hyperoxia Therapy (VHT™), their patented and FDA-510(k)-cleared technology that represents a breakthrough in treating diabetic foot ulcers (DFUs).